Coya Therapeutics, Inc. (COYA)
5.01
+0.12
(+2.45%)
USD |
NASDAQ |
Sep 21, 16:00
5.01
0.00 (0.00%)
After-Hours: 20:00
Coya Therapeutics Total Assets (Quarterly) : 47.31M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 47.31M |
| March 31, 2026 | 53.27M |
| December 31, 2025 | 49.95M |
| September 30, 2025 | 32.04M |
| June 30, 2025 | 33.45M |
| March 31, 2025 | 38.40M |
| December 31, 2024 | 44.35M |
| September 30, 2024 | 35.55M |
| June 30, 2024 | 39.94M |
| March 31, 2024 | 37.54M |
| Date | Value |
|---|---|
| December 31, 2023 | 41.27M |
| September 30, 2023 | 11.90M |
| June 30, 2023 | 14.47M |
| March 31, 2023 | 17.42M |
| December 31, 2022 | 8.396M |
| September 30, 2022 | 9.064M |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | 4.792M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 2.112B |
| Oncolytics Biotech, Inc. | 7.671M |
| Sangamo Therapeutics, Inc. | 59.96M |
| Sarepta Therapeutics, Inc. | 3.189B |
| Anixa Biosciences, Inc. | 15.07M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 4.032M |
| Shareholders Equity (Quarterly) | 43.28M |
| Current Ratio | 13.40 |